DoBrain Raises KRW 21 Billion to Enhance Cognitive Development Services
South Korean digital healthcare startup DoBrain has secured a KRW 21 billion Series B investment. InterVest, a new investor, led the round with a KRW 15 billion contribution, joined by a domestic insurance company and existing investor KB Investment.
DoBrain is pioneering a digital healthcare model that overcomes location and cost limitations. They offer a comprehensive range of services, from personalized cognitive training programs through their DoBrain2 app for children’s cognitive development to “D-kit,” designated as an innovative medical device in December 2022. They also provide online coaching classes for caregivers known as “WeVillee Homes,” alongside WeVillee Kids, an offline treatment center recognized by the QABA as an ABAT-certified institution.
DoBrain is preparing for FDA certification to register its cognitive digital therapeutic (DTx) solutions in the United States.
With this new investment, DoBrain aims to focus on developing services and products that address the challenges faced by children with varying developmental needs and their families. DoBrain’s mission is to make the world a place where more children can receive the support they need for their development, similar to a hospital on the moon.
DoBrain’s app has been downloaded over 600,000 times worldwide, with a retention rate of over 90%. It is actively used in various countries, including Cambodia, India, the United States, and Dubai.
[Korean bioHealth Startups News]
- SEOUL BIOHUB Global Center Opens, Aiming to Boost Global BioTech Competitiveness
- Delight Room Invests in Soundable Health for Advanced Sound Analysis in Healthcare
- Apollon Secures 2.3 Billion KRW in Funding for Innovative Needle-Free CGM Technology
- Korean Space Medicine Startup SpaceLiintech Lands 4 Billion KRW Series A Funding
- ArtBlood Secures KRW 6.5 Billion in Series A for Synthetic Blood Production
- GLOUD Raises 3B KRW in Pre-Series A for Global Dental Digital Transformation Expansion
- Protium Science and HK innoN Forge Strategic Investment & Partnership
- LabInCube Raises KRW 5.1B in Series A for MOF Material Development
- Prevenotics Secures Investment for AI-Based Cancer Prevention from 500 Global
- Syntekabio Secures KRW 10B for AI Drug Development from Korea Investment Partners
